Exploring the implications for coincidental treatment of Mycoplasma genitalium infection in Neisseria gonorrhoeae-positive patients

Affiliations

¹ The University of Queensland Centre for Clinical Research (UQ-CCR), Queensland, Australia.
² Gold Coast Sexual Health & HIV Service, Queensland, Australia.
³ Pathology Queensland Central Laboratory, Queensland, Australia.

Lebogang P Mhango et al. JAC Antimicrob Resist. 2021.

. 2021 Mar 16;3(1):dlab033.

doi: 10.1093/jacamr/dlab033. eCollection 2021 Mar.

¹ The University of Queensland Centre for Clinical Research (UQ-CCR), Queensland, Australia.
² Gold Coast Sexual Health & HIV Service, Queensland, Australia.
³ Pathology Queensland Central Laboratory, Queensland, Australia.

No abstract available

References

1. Getman D, Jiang A, O’Donnell M. et al. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol 2016; 54: 2278–83. - PMC - PubMed
1. Australian STI Management Guidelines. Mycoplasma genitalium. http://www.sti.guidelines.org.au/sexually-transmissible-infections/mycop....
1. Manhart LE. Mycoplasma genitalium on the loose: time to sound the alarm. Sex Transm Dis 2017; 44: 463–5. - PMC - PubMed
1. Birger R, Saunders J, Estcourt C. et al. Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model. Sci Rep 2017; 7: 16162. - PMC - PubMed
1. Broad C, Harding-Esch E, Harrison M. et al. O12.2 Co-infection and macrolide antimicrobial resistance (AMR) of Mycoplasma genitalium with Neisseria gonorrhoeae and Chlamydia trachomatis, in females, heterosexual males, and men-who-have-sex-with-men. Sex Transm Infect 2017; 93 Suppl 2: A27.